refractory autoimmune Evans syndrome: a two or three packed red blood cell concentrates were given cautionary case report per day and six random-donor platelet units or single-donor apheresis units (when available) were tranfused every 12 or 8 h, although the post-transfusion platelet count was always In the April (1) 1997 issue of Bone Marrow Transplan-Ͻ10 ϫ 10 9 /l. Anti-HLA platelet alloantibodies were not tation Dr Tyndall and Dr Gratwohl report on the recpresent. Neutropenia lasted from day 7 to day 12, but on ommendations given by a group of expert European rheumday 9, 3% of 1.5 ϫ 10 9 /l WBC expressed the CD34 ϩ antiatologists and hematologists/oncologists regarding the use gen, and a single leukapheresis on that day yielded a proof stem cell transplantation in patients with autoimmune duct with 3.2 ϫ 10 6 /kg CD34 ϩ cells. On day 10, high-dose diseases, including autoimmune cytopenias.
1 Some recent IVIG (400 mg/kg for 5 days) was added, but her mucosal anecdotal reports of successful APBSCT in patients with bleeding worsened, and she died on day 16 from an intrarefractory autoimmune thrombocytopenic purpura have cranial hemorrhage. confirmed the potential application of this procedure even
The most probable cause for this patient's abrupt in advanced refractory cases.
2 However, mobilization of increase in the bleeding diathesis was the inhibition of a PBSC with chemotherapy plus G-CSF may pose unexpechyperactive hematopoiesis without a concomitant decrease ted risks in this setting due to the abrupt inhibition of a in the autoimmune peripheral destruction of both PLT and hyperplastic hematopoietic system. RBC. Her stable basal situation before mobilization was A 19-year-old white female was diagnosed with primary probably maintained due to the hyperproduction of PLT autoimmune hemolytic anemia and autoimmune thromand reticulocytes, despite the low peripheral blood counts. bocytopenic purpura (Evans syndrome) in 1993. Prednisone
Cyclophosphamide interrupted this compensatory mechand danazol initially obtained a partial response, but in anism and led to the patient's severe bleeding compli-1994 she underwent splenectomy due to a severe recurcations, with no lasting response to the hypertransfusion of rence. Only a transient partial response was obtained, and PLT and RBC. This unfortunate case leads us to reover the following 2 years she developed various severe commend mobilizing patients with refractory or relapsed relapses which were treated with high-dose methylpredniautoimmune cytopenias only, if possible, after at least a solone, cyclosporine, vincristine and intravenous immunostable response is obtained with a salvage treatment. In this globulins (IVIG). In November 1996, she developed situation, the myelosuppressive effect of the chemotherapy another severe recurrence, and two cycles of combination may be better tolerated, or the use of G-CSF alone without chemotherapy with cyclophosphamide, vincristine and concomitant chemotherapy may suffice to harvest prednisone were given after stabilization with IVIG. Howsufficient PBSC. ever, her condition progressed and in January 1997 a decision was taken to mobilize PBSC for a later APBSCT. R Martino Unitat d'Hematologia Clinica, Prior to mobilization her clinical condition was stable with A Sureda Hospital de Sant Pau, no major bleeding and a Karnofsky performance of 60%.
S Brunet Barcelona, Spain Red blood cell transfusions were required once or twice a week and platelet transfusions every 2 to 3 days. The bone marrow was hyperplastic and the reticulocyte count was References very high (0.3 ϫ 10 12 /l (normal 0.02-0.1)) with signs of active hemolysis; the platelet count was persistently Ͻ5 ϫ until day 5 when her reticulocyte count dropped to 0 with
